Organoids are game changers not only for cancer research but also as tools to understand toxicity of drugs and for the development of personalized treatments. These 3-D models of human organ tissue allow scientists to perform preclinical in vitro investigation of normal or diseased tissue, and are a focus of the Human Cancer Models Initiative (HCMI).